Technology | October 07, 2013

Claron to Debut Enhanced Modality Support for Nil Universal Viewers

remote viewing system rsna 2013 claron nil universal viewer nilread

October 7, 2013 — Claron Technology will announce extended modality support for its Nil universal zero-footprint medical viewers at the Radiological Society of North America (RSNA) 2013 conference. The Nil viewer family includes NilShare, optimized for enterprise viewing, and NilRead, newly U.S. Food and Drug Administration (FDA)-cleared for diagnostic use. Also new at RSNA is support for high-definition MPEG-4 videos as well as all common image formats including JPEG, TIFF and PNG. The viewers now support full cross-enterprise document sharing (XDS), integrating healthcare enterprise (IHE) profiles, including comprehensive health level 7 (HL7) clinical document architecture (CDA) documents. The Nil viewer family is optimized for cache-less integration with remote archives, including picture archiving and communication systems (PACS) and vender neutral archives (VNA), streaming data without caching it. This allows Nil to provide the best user experience for the clinical workflow typical of universal viewers, where it is not possible to optimize data access based on a scheduled workflow.

For more information: www.clarontech.com

Related Content

Updated AATS Guidelines Help Cardiovascular Surgeons Navigate Challenges of Managing Ischemic Mitral Regurgitation
News | Heart Valve Technology| April 20, 2017
April 20, 2017 — Mitral regurgitation can occur in up to 50 percent of patients with ischemic heart disease and even

Physicians will need to use a CMS-certified appropriate use criteria (AUC) clinical decision support software that documents the appropriateness of an imaging order to receive full reimbursement for Medicare patients starting Jan. 1, 2018.

Feature | Cardiac Imaging| April 18, 2017 | Dave Fornell
As part of U.S. healthcare reform efforts, starting Jan.
Cardiovascular Institute of the South Upgrades Cardiac Ultrasound With New Toshiba Medical Systems
News | Cardiovascular Ultrasound| April 17, 2017
April 17, 2017 — To bolster its technology and treatment capabilities for coronary and peripheral artery diseases acr
ASE, EACVI, focused update document, aortic stenosis, AS, echocardiography, new classification scheme
News | Cardiovascular Ultrasound| April 03, 2017
The American Society of Echocardiography (ASE) and the European Association of Cardiovascular Imaging (EACVI) have...
Philips, cardiology solutions, ACC.17, Azurion angiography system, iFR outcomes results, IntelliSpace Cardiovascular
News | Cardiac Imaging| March 24, 2017
At the 2017 American College of Cardiology's Annual Scientific Session & Expo (ACC.17), Philips showcased a broad...
Agfa HealthCare, Enterprise Imaging for Cardiology, ACC.17, IBM Watson Health
Technology | Enterprise Imaging| March 20, 2017
March 20, 2017 — Agfa HealthCare announced the release a new version of its...
Toshiba Medical, Aplio i900 cardiovascular ultrasound, FDA clearance, ACC 2017, RSNA 2017
Technology | Cardiovascular Ultrasound| March 20, 2017
March 20, 2017 — Cardiologists can now access the advanced...
valve regurgitation, ASE, new guidelines, imaging, evaluation, SCMR, echocardiography, ultrasound, cardiac MRI
News | Cardiovascular Ultrasound| March 16, 2017
A new document from the American Society of Echocardiography (ASE) provides a comprehensive update to guide clinicians...
PET imaging, atherosclerotic plaque, inflammation, Ga-68-pentixafor, Technishe Universitat Munchen, Germany

Note the high uptake of Ga-68-pentixafor on multi-planar reconstructions in the organs expressing CXCR4 such as the spleen (red arrows) and adrenal glands (yellow arrows), which was nearly completely blocked by the pre-injection of AMD 3100, a potent CXCR4 inhibitor. Strong accumulation of Ga-68-pentixafor was also found in the kidneys (asterisks) reflecting the renal clearance of the tracer. In addition, high, focal activities were detected in the abdominal aorta (red arrowheads) and right carotid artery (orange arrowheads) of atherosclerotic rabbits, whereas no significant signal could be detected in the non-injured left carotid artery (white arrowheads) of atherosclerotic and control rabbits, as well as in the abdominal aorta and right carotid artery of control rabbits. Furthermore, focal activities detected with PET in atherosclerotic plaques of the abdominal aorta and the right carotid artery decreased significantly when the same rabbit was re-imaged after blocking CXCR4 receptors. Image courtesy of Fabien Hyafil, M.D., Ph.D., Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

News | PET Imaging| March 03, 2017
In the featured article of the March 2017 issue of The Journal of Nuclear Medicine, researchers demonstrate that a new...
Sponsored Content | Videos | Artificial Intelligence| March 01, 2017
Machine learning is now being commercialized in medical imaging products designed to help improve workflow efficiency
Overlay Init